Gilead Sciences
GILD
GILD
1,552 hedge funds and large institutions have $66.1B invested in Gilead Sciences in 2019 Q4 according to their latest regulatory filings, with 184 funds opening new positions, 501 increasing their positions, 697 reducing their positions, and 71 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
4% less call options, than puts
Call options by funds: $1.4B | Put options by funds: $1.46B
14% less funds holding in top 10
Funds holding in top 10: 43 → 37 (-6)
28% less repeat investments, than reductions
Existing positions increased: 501 | Existing positions reduced: 697
Holders
1,552
Holding in Top 10
37
Calls
$1.4B
Puts
$1.46B
Top Buyers
| 1 | +$542M | |
| 2 | +$420M | |
| 3 | +$181M | |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
+$173M |
| 5 |
Renaissance Technologies
New York
|
+$145M |
Top Sellers
| 1 | -$766M | |
| 2 | -$175M | |
| 3 | -$156M | |
| 4 |
PI
Putnam Investments
Boston,
Massachusetts
|
-$145M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$128M |